|
|
|
Insider
Information: |
Winger Dennis L |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
288,465 |
|
Indirect Shares
|
11,500 |
|
|
Direct
Value |
$3,916,388 |
|
|
Indirect Value
|
$3,130,595 |
|
|
Total
Shares |
299,965 |
|
|
Total
Value |
$7,046,983 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Applera-Applied Biosys |
ABI |
Senior Vice President ... |
2008-11-21 |
0 |
2003-07-11 |
0 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
Director |
2006-08-11 |
69,544 |
2003-07-25 |
0 |
Premium* |
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2012-03-09 |
6,500 |
2010-02-16 |
6,500 |
Premium* |
|
Accuray Inc |
ARAY |
Director |
2017-11-30 |
162,181 |
2010-11-30 |
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2018-08-21 |
42,750 |
2018-08-21 |
5,000 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2017-06-14 |
7,490 |
2014-12-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
208 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-13 |
4 |
S |
$61.04 |
$1,045,310 |
D/D |
(17,125) |
59,875 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-14 |
4 |
S |
$60.15 |
$1,030,069 |
D/D |
(17,125) |
42,750 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-17 |
4 |
OE |
$14.26 |
$213,900 |
D/D |
15,000 |
57,750 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-17 |
4 |
S |
$59.62 |
$894,300 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-21 |
4 |
OE |
$14.26 |
$213,900 |
D/D |
15,000 |
57,750 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-21 |
4 |
S |
$60.30 |
$904,500 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2003-08-22 |
4/A |
D |
$10.46 |
$14,675 |
D/D |
(1,403) |
25,556 |
|
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2003-08-22 |
4/A |
D |
$21.31 |
$119,521 |
D/D |
(5,610) |
86,692 |
|
- |
|
208 Records found
|
|
Page 9 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|